Fire1 announced today that it completed a $120 million financing round to accelerate the advancement of its heart failure management system. The company also reached a major FDA milestone with breakthrough device designation. The agency also accepted its technology into its Total Product Lifecycle Advisory Program (TAP). TAP provides early and frequent strategic engagement from […]
Fire1
Fire1 raises $25M for at-home heart failure monitoring tech with investment from Medtronic
Fire1 announced today that it closed a $25 million financing round — with investment from Medtronic — to support its novel remote monitoring technology. New investors Andera Partners and Novo Holdings led the round. Existing investors Gilde Healthcare, Gimv, the Ireland Strategic Investment Fund, Lightstone Ventures, Medtronic, New Enterprise Associates and Seventure Partners also participated. […]
Fire1 raises $50m in Series C to support novel HF patient monitor
Connected health company Fire1 said yesterday it closed a $49.7 million (EU €40 million) Series C round to support further development of its novel remote monitoring system designed for heart failure patients. The round was led by newly invested Gilde Healthcare and joined by newly invested Gimv and Seventure. All existing investors, including Medtronic (NYSE:MDT), Lightstone Ventures […]
Foundry spinout Fire1 raises $7.5m Series B
Stealthy Irish medical device startup Fire1 said today that its investors, including Medtronic (NYSE:MDT), put up another $7.5 million for its Series B round. Dublin-based Fire1, a spinout from medical device incubator The Foundry, also said it tapped former ResMed (NYSE:RMD) executive Conor Hanley to be its president & CEO and added another pair of senior […]
GI Dynamics raises $32M in private placement with group overseas | Medtech funding stories for the week of May 5, 2014
Lightstone targets medtech and lifesciences with new $172M fund

Lightstone Ventures is ready to make some disruptive companies with its newly raised $172 million medtech and lifesciences fund, saying that market outlooks are promising for new products.